findmyKOL
Clinical trialNCT01180036CompletedPhase 2/PHASE3Interventional

MEmbranous Nephropathy Trial Of Rituximab

SponsorMayo ClinicEnrollment130Idiopathic Membranous Nephropathy
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

21 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • St. Paul'S Hospital, Providence Health Care

    Vancouver, British Columbia, Canada

  • Toronto General Hospital

    Toronto, Ontario, Canada

  • Centre Hospitalier Universitaire de Quebec - Hotel-Dieu de Quebec

    Québec, Canada

United States
  • University of Alabama at Birmingham

    Birmingham, Alabama, United States

  • Mayo Clinic Scottsdale

    Scottsdale, Arizona, United States

  • University of Arizona, Tucson

    Tucson, Arizona, United States

  • Stanford University

    San Francisco, California, United States

  • Mayo Clinic Jacksonville

    Jacksonville, Florida, United States

  • University of Miami Hospital and Clinics

    Miami, Florida, United States

  • University of Kansas Medical Center

    Kansas City, Kansas, United States

  • University of Michigan

    Ann Arbor, Michigan, United States

  • Mayo Clinic Rochester

    Rochester, Minnesota, United States

  • University of Mississippi Medical Center

    Jackson, Mississippi, United States

  • Washington University School of Medicine

    St Louis, Missouri, United States

  • Columbia University Medical Center

    New York, New York, United States

  • New York University

    New York, New York, United States

  • Cleveland Clinic

    Cleveland, Ohio, United States

  • Metrohealth System (case Western Reserve University)

    Cleveland, Ohio, United States

  • Ohio State University

    Columbus, Ohio, United States

  • University of Washington Medical Center

    Seattle, Washington, United States

  • Medical College of Wisconsin, Froedtert Hospital

    Milwaukee, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Nov 2011
Primary completion
1 Oct 2017
Completion
1 Oct 2017
Last update posted
30 Apr 2019
Registered enrollment
130
Registry id
NCT01180036

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.